IRA Impact on Biopharma Drug Development

from Rx for Biotech Hosted by Podcast Host Christopher Leidli

The Inflation Reduction Act was signed into law in August 2022 and is one of the most significant pieces of healthcare reform since the Affordable Care Act. In this episode, learn more about how the new policy will impact R&D portfolio decision making and new product development strategies.

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

IRA Impact on Biopharma Drug Development

0:00 10:14

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently asked questions

How long is this episode of Rx for Biotech?

This episode is 10 minutes long.

When was this Rx for Biotech episode published?

This episode was published on October 7, 2022.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.